TY - JOUR T1 - An evaluation of the hospital smoking-cessation services in Portugal JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2021.PA3209 VL - 58 IS - suppl 65 SP - PA3209 AU - Sofia Belo Ravara AU - Mariana Silva Ribeiro AU - Hilson Cunha Filho Y1 - 2021/09/05 UR - http://erj.ersjournals.com/content/58/suppl_65/PA3209.abstract N2 - AIM Smoking cessation (SC) health service research is scarce. We sought to explore the level of implementation of hospital SC services (HSCS) in Portugal. METHODS Cross-sectional study. We asked the HSCS' coordinators to fill both a self-audit questionnaire validated by a Delfi methodology; and open questions delivered by e-mail. The self-audit evaluates the implementation level by using a likert-scale (range: 0-4) through several items across 8 different dimensions (human/logistics resources/good practice/sub-populations of smokers/training/assessment/research practice/community reach). We performed a descriptive analysis and compared the mean score of the 8 dimensions among services by region, dimension/type of hospital. RESULTS We gathered 27 valid questionnaires (84% participation rate; 75% of the services in Portugal mainland). We observed regional inequalities in the distribution of HSCS in South of Portugal. Most HSCS were led by lung physicians; only 2 HSCS delivered a group-based SC; few targeted special populations of smokers. Higher mean scores (>3/4) were obtained in the level of training and good practices and logistic resources. Lower mean scores (2/4) were observed in items regarding cessation outcomes assessment, participation in research and community reach activities. These trends were similar across all regions and hospital type, except for community reach which was statistically significantly higher in smaller hospitals. CONCLUSION There is a need for hospital smoking-cessation targeting special populations and chronic diseases management programmes; as well as for assessment of smoking-cessation outcomes and community reach activities.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3209.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -